MNPR RSI Chart
Last 7 days
-9.0%
Last 30 days
-6.1%
Last 90 days
79.4%
Trailing 12 Months
-30.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 0 | 0 | 0 | 0 |
2021 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 31, 2024 | robinson chandler | sold (taxes) | -4,884 | 0.681 | -7,172 | chief executive officer |
Mar 31, 2024 | tsuchimoto kim r | acquired | - | - | 9,956 | chief financial officer |
Mar 31, 2024 | robinson chandler | acquired | - | - | 24,474 | chief executive officer |
Mar 31, 2024 | tsuchimoto kim r | sold (taxes) | -2,779 | 0.681 | -4,082 | chief financial officer |
Mar 31, 2024 | cittadine andrew | acquired | - | - | 8,952 | chief operating officer |
Mar 31, 2024 | cittadine andrew | sold (taxes) | -2,109 | 0.681 | -3,098 | chief operating officer |
Jan 01, 2024 | robinson chandler | acquired | - | - | 6,724 | chief executive officer |
Jan 01, 2024 | tsuchimoto kim r | sold (taxes) | -171 | 0.3402 | -505 | chief financial officer |
Jan 01, 2024 | tsuchimoto kim r | acquired | - | - | 1,231 | chief financial officer |
Jan 01, 2024 | robinson chandler | sold (taxes) | -791 | 0.3402 | -2,327 | chief executive officer |
Which funds bought or sold MNPR recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | MORGAN STANLEY | unchanged | - | 273 | 545 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | new | - | 340 | 340 | -% |
May 15, 2024 | Federation des caisses Desjardins du Quebec | new | - | 108 | 108 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 117 | 4,120 | 5,350 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 555 | 121,035 | 131,011 | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | sold off | -100 | -4,866 | - | -% |
May 15, 2024 | Royal Bank of Canada | new | - | - | - | -% |
May 14, 2024 | NewEdge Advisors, LLC | new | - | 2,043 | 2,043 | -% |
May 13, 2024 | HRT FINANCIAL LP | new | - | 21,000 | 21,000 | -% |
May 13, 2024 | FMR LLC | new | - | 3,746 | 3,746 | -% |
Unveiling Monopar Therapeutics Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Monopar Therapeutics Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Monopar Therapeutics Inc News
Income Statement (Quarterly) | |||
Description | (%) Q/Q | 2023Q1 | 2021Q1 |
Revenue | -92.6% | 807 | 10,925 |
Operating Expenses | 33.3% | 2,525 | 1,895 |
S&GA Expenses | 26.7% | 872 | 688 |
R&D Expenses | 37.0% | 1,653 | 1,207 |
Interest Expenses | 746.0% | 90.00 | 11.00 |
Net Income | -29.2% | -2,434 | -1,884 |
Free Cashflow | -Infinity% | -2,271 | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 21.3% | 9.00 | 7.00 | 9.00 | 10.00 | 12.00 | 13.00 | 14.00 | 17.00 | 18.00 | 21.00 | 23.00 | 24.00 | 26.00 | 17.00 | 18.00 | 13.00 | 13.00 | 13.00 | 5.00 | 6.00 | 6.00 |
Current Assets | 21.5% | 9.00 | 7.00 | 9.00 | 10.00 | 12.00 | 13.00 | 14.00 | 17.00 | 18.00 | 21.00 | 22.00 | 24.00 | 26.00 | 17.00 | 18.00 | 13.00 | 13.00 | 13.00 | 5.00 | 6.00 | 6.00 |
Cash Equivalents | 7.5% | 8.00 | 7.00 | 6.00 | 7.00 | 6.00 | 8.00 | 14.00 | 16.00 | 18.00 | 20.00 | 22.00 | 24.00 | 26.00 | 17.00 | 18.00 | 13.00 | 13.00 | 13.00 | 4.00 | 5.00 | 6.00 |
Liabilities | -18.3% | 1.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 1.00 | 2.00 | 1.00 | 1.00 | - | 1.00 | 1.00 | 1.00 | 0.00 | 1.00 | 0.00 | 0.00 | 1.00 |
Current Liabilities | -100.0% | - | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 1.00 | 2.00 | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 1.00 | 0.00 | 0.00 | 1.00 |
Shareholder's Equity | 33.8% | 7.00 | 6.00 | 7.00 | 8.00 | 9.00 | 10.00 | 13.00 | 15.00 | 17.00 | 19.00 | 21.00 | 23.00 | 25.00 | 16.00 | 17.00 | 12.00 | 12.00 | 13.00 | 5.00 | 5.00 | 6.00 |
Retained Earnings | -2.6% | -61.80 | -60.21 | -58.40 | -56.44 | -54.24 | -51.80 | -48.91 | -46.51 | -43.75 | -41.29 | -38.61 | -36.15 | -34.07 | -32.19 | -30.06 | -28.42 | -26.97 | -25.88 | -24.67 | 0.00 | -23.03 |
Additional Paid-In Capital | 5.3% | 69.00 | 66.00 | 65.00 | 64.00 | 63.00 | 62.00 | 61.00 | 61.00 | 61.00 | 60.00 | 60.00 | 59.00 | 59.00 | 48.00 | 48.00 | 41.00 | 39.00 | 39.00 | 29.00 | 29.00 | 29.00 |
Shares Outstanding | 17.3% | 17.00 | 15.00 | 14.00 | 14.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 5.00 | - | - | - | 10.00 | - | - | - | 25.00 | - | - | - | 17.00 | - | - | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -7.1% | -1,655 | -1,545 | -1,939 | -2,101 | -2,271 | -1,301 | -2,148 | -1,310 | -2,467 | -2,031 | -1,941 | -1,406 | -1,938 | -1,240 | -1,300 | -995 | -1,125 | -668 | -613 | -739 | -995 |
Share Based Compensation | -30.7% | 329 | 474 | 474 | 473 | 476 | 393 | 391 | 357 | 500 | 350 | 392 | 358 | 368 | 331 | 284 | 367 | 338 | 277 | 243 | 258 | 234 |
Cashflow From Investing | -133.1% | -983 | 2,970 | -13.05 | 2,954 | -983 | -4,918 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow From Financing | 851.1% | 3,182 | 335 | 247 | 641 | 805 | 139 | -23.74 | -65.46 | -16.67 | -7.77 | -9.98 | -24.00 | 10,921 | -7.14 | 6,735 | 946 | 508 | 9,387 | -13.28 | -12.32 | -13.85 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 966,110 | $ 1,653,369 |
General and administrative | 757,281 | 871,675 |
Total operating expenses | 1,723,391 | 2,525,044 |
Loss from operations | (1,723,391) | (2,525,044) |
Interest income | 82,165 | 90,488 |
Net loss | (1,641,226) | (2,434,556) |
Other comprehensive income (loss): | ||
Foreign currency translation loss | (835) | (10,800) |
Unrealized gain on investments | 19,198 | 33,645 |
Comprehensive loss | $ (1,622,863) | $ (2,411,711) |
Net loss per share: | ||
Basic and diluted (in dollars per share) | $ (0.1) | $ (0.19) |
Weighted average shares outstanding: | ||
Basic and diluted (in shares) | 15,979,816 | 13,105,831 |
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 7,807,579 | $ 7,266,080 |
Investments | 985,730 | 0 |
Other current assets | 118,987 | 66,433 |
Total current assets | 8,912,296 | 7,332,513 |
Operating lease right-of-use asset | 0 | 12,646 |
Total assets | 8,912,296 | 7,345,159 |
Current liabilities: | ||
Accounts payable, accrued expenses and other current liabilities | 1,435,160 | 1,757,393 |
Total current liabilities and total liabilities | 1,435,160 | 1,757,393 |
Commitments and contingencies (Note 8) | ||
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 17,484,175 and 14,904,497 shares issued and outstanding at March 31, 2024, and December 31, 2023, respectively | 17,484 | 14,905 |
Additional paid-in capital | 69,302,864 | 65,793,210 |
Accumulated other comprehensive income (loss) | 4,231 | (14,132) |
Accumulated deficit | (61,847,443) | (60,206,217) |
Total stockholders’ equity | 7,477,136 | 5,587,766 |
Total liabilities and stockholders’ equity | $ 8,912,296 | $ 7,345,159 |